Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Meta Privacy Verdict Raises Stakes For Website Data Tracking No Photo Available

Allison Grande

A California federal jury's move to hold Meta accountable for unauthorized receipt of sensitive health data gathered through a popular... (more story)

States Push Anti-mRNA Bills Amid Growing Public Distrust No Photo Available

Mark Payne

Public distrust was a key motivator for the federal government's decision to cut contracts developing messenger RNA vaccines. The sent... (more story)

New Barriers To Health Safety Net Spark Questions, Litigation No Photo Available

Gianna Ferrarin

Federal health officials' reinterpretation of a decades-old social welfare law is expected to boot thousands of noncitizens from safet... (more story)